The latest news & stories from the Providence Research Network
-
Read ArticleDark genome, bright outcome: A first-of-its-kind trial gives Del Abbott a second chance
Del survived Arctic winters, a demanding career and cancer – twice. Here’s how a pioneering Providence Cancer Institute trial helped him beat it a second time.
-
Read ArticleA new liver cancer trial explores a “two-in-one" treatment approach
Providence Cancer Institute is enrolling patients with hepatocellular carcinoma in a trial of pumitamig, an investigational bispecific antibody.
-
Read ArticleProvidence and Arizona State University receive Stand Up To Cancer grant to advance next-generation cancer immunotherapy
Grant‑funded collaboration focuses on mRNA vaccine technology to strengthen personalized T‑cell therapies for pancreatic cancer
-
Read ArticleCan a ‘well-being leadership’ program reduce burnout among frontline clinicians?
New research from Providence suggests that a specialized training for frontline clinicians could help address drivers of healthcare workforce burnout.
-
Read ArticleProvidence Cancer Institute secures three significant grants
Prestigious grants will help researchers pursue important cancer studies.
-
Read ArticleHow AI is helping advance cancer research at Providence Swedish
Providence Swedish is harnessing the power of "big data" in medicine to accelerate biomedical research. Learn more.
-
Read ArticleQ&A: Meet one of the investigational drug pharmacists at Providence
An inside look at how a pharmacist at Providence Cancer Institute keeps clinical trials running safely, one dose at a time.
-
Read ArticleAfter a shocking diagnosis, transformative care and a mission to support research
After facing a life-altering brain tumor, this Providence Swedish patient discovered clarity, gratitude, and a mission to support the research that guided her care.
-
Read ArticleNew T-cell therapy for KRAS G12D cancers
An expanded access program uses engineered T cells to target the KRAS G12D mutation in pancreatic, colorectal or other advanced cancers.
-
Read ArticleHope comes in a clinical trial: Brad’s remarkable story
When Brad’s medullary thyroid cancer returned after a surgical procedure, he enrolled in a clinical trial. Now, his cancer is nearly undetectable.
-
Read ArticleNew research offers hope to patients with autoimmune diseases like lupus
For patients living with autoimmune diseases, every day can be a challenge. But now, a research breakthrough using CAR T cellular therapy could change the story.
-
Read ArticleWhen standard treatment isn’t enough: A new study offers hope for people with triple-negative breast cancer
A new clinical trial is testing a promising drug combination that could improve survival for people whose cancer didn’t fully respond to standard treatment.
-
Read ArticleAdvancing cancer care through clinical trials
Providence Cancer Institute is connecting patients with new possibilities for care — often close to home — through innovative clinical trials.
-
Read ArticleProvidence research in the news: Developing a platform to predict mental health crises
A July 2026 news story in the publication Catholic Health World highlights Providence’s participation in a groundbreaking research project aimed at helping predict mental health crises.
-
Read ArticleBringing breakthrough heart care home in Montana
Learn how the Providence Montana Heart Institute is working to bring world-class clinical research and the latest heart care and treatment options closer to Montana communities.
-
Read ArticleAI and Cancer treatment
The goal is to create a digital representation—or medical twin—of a patient and use advanced AI to understand what treatments work best and provide more informed options about the most effective paths
-
Read ArticleNew research could help bring more women into interventional cardiology
New radiation safety research from Providence CARDS and Providence Heart Institute of Oreogn could help bring more women into interventional cardiology
-
Read ArticleProvidence Swedish Neuroscience Institute (PSNI) Reaches Milestone in Reducing Global Burden of Glioblastoma
PSNI collaborates with Seattle-based HDT Bio on preparations for trialing novel treatment to breach blood-brain barrier
-
Read ArticleProvidence study finds AI ambient listening tool modestly reduces documentation burden, improves provider efficiency
Published in JAMA Network Open, a new Providence study uses real-world data to show how AI ambient listening reduces documentation burden, improving efficiency and clinician focus on patient care.
-
Read ArticleLessons from an innovative workforce housing project | CORE
Based on research around the innovative Hawk's Eye Apartments project in Clatsop County, Oregon, Providence CORE offers five key takeaways for healthcare investments in affordable workforce housing.
-
Loading More...
